Taro Pharmaceuticals U.S.A., Inc. recalls Ibuprofen Oral Suspension USP, 100 mg/5 mL, One Pint, (473 mL), Rx only, Manufactured by: Taro Pharmaceuticals Inc.,
Taro Pharmaceuticals recalls ibuprofen oral suspension with small plastic particles from specific lots. Consumers should check product details and contact Taro for guidance.
Lower-risk recall
Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
Contact the company & request your remedy
What happened, in plain English
Taro Pharmaceuticals is recalling ibuprofen oral suspension products that may contain small plastic particles from manufacturing. This could cause choking or injury if the particles are ingested. Read more at govinfonow.com/recall/37897-taro-ibuprofen-suspension-recall-foreign-plastic-particles-in-product.
Source Summary by GovInfoNow · govinfonow.com/recall/37897-taro-ibuprofen-suspension-recall-foreign-plastic-particles-in-product · Updated October 5, 2026 · FDA enforcement record: FDA #D-0299-2020
Cite this page
“Taro Ibuprofen Suspension Recall: Foreign Plastic Particles in Product.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37897-taro-ibuprofen-suspension-recall-foreign-plastic-particles-in-product. Based on FDA recall #D-0299-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0299-2020%22&limit=1).
Why it’s dangerous
The suspension may have small plastic particles introduced during manufacturing. If ingested, these particles could cause choking or injury. However, the risk is low as the particles are small and the product is for prescription use only.
Who’s affected
People who have the recalled ibuprofen oral suspension product (100 mg/5 mL, one pint) with specific lot numbers and expiration dates listed in the recall. Those who use the product for pain relief are most at risk.
How to tell if you have this one
Check the product label for the lot number and expiration date. The recalled products have specific lot numbers and expiration dates listed in the recall notice, such as J78402968 (exp 9/19) or A887230568 (exp 12/19).
- Brand
Taro Pharmaceuticals- Category
Drug
All 5 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
U.S.A. Nationwide
| Recall number | Product, codes & lots | Quantity | NDC |
|---|---|---|---|
| D-0298-2020 | Ibuprofen Oral Suspension USP, 100 mg/5 mL, 4 fl. oz., (118 mL), Rx only, Manufactured by: Taro Pharmaceuticals, Inc., Brampton, Ontario, Canada L6T 1C1, Distributed by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1385-8; Lot #: K779030125, Exp 10/19; D873031376, Exp 3/20; J871233188, Exp 9/20; L866934047, Exp 11/20; A973134376, 12/20; D967635229, Exp 3/21 | 138,886 bottles | 51672-1385-8, 51672-1385-9 |
| D-0299-2020 | Ibuprofen Oral Suspension USP, 100 mg/5 mL, One Pint, (473 mL), Rx only, Manufactured by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Distributed by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1385-9; Lot #: J78402968, J784129698, Exp 9/19; K765129698, K765229698, K765329698, K769329698, K778829698, K778929698, Exp 10/19; A887230568, A887330568, A887430568, Exp 12/19; B865430568, B865530568, B865630568, B869530568, B869630568, Exp 1/20; D866431198, D866531198, D866631198, D866731198, D866831198, D866931198, D872631198, D872731198, D872831198, D872931198, D873031834, Exp 3/20; E875331834, E875431834, E883831834, E883931834, E884031834, E884131834, Exp 4/20; F865131834, Exp 5/20; G879432436, G879532436, G879632436, G879732436, G879832436, G879932436, G881632436, G882232436, Exp 6/20; H865232436, H865332436, H870832436, Exp 7/20; I885233156, I885333156, I885433156, I885533156, I885633156, I885733164, Exp 8/20; J868533164, J868633164, J868733164, J868833164, J868933164 and J869033164, Exp 9/20; L866434042, L866534043, L866634044, L866734045, L866834046, L866934422, Exp 11/20; A973134748, A973234423, A973334424, A979534425, A979634426, A979734427, A979834428, Exp 12/20; B974034749, B974134750, B974234751, B974334752, B974434753, Exp 1/21 | 639,325 bottles | 51672-1385-8, 51672-1385-9 |
| D-0300-2020 | Children's Ibuprofen Oral Suspension USP, 100 mg per 5 mL, Berry Flavor, Dye-Free, Alcohol Free, 4 fl. oz. (120 mL), Distributed by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-2130-8; Lot #: E875131667, E875231667, Exp 4/20; J871033189, J871133189, Exp 9/20; A972934375, A973034375, Exp 12/20 | 182,986 bottles | 51672-2130-8, 51672-2130-1 |
| D-0301-2020 | Children's Ibuprofen Oral Suspension USP, 100 mg per 5 mL, Berry Flavor, Dye-Free, Alcohol Free, 8 fl. oz.(240 mL), Distributed by: Taro Pharmaceuticals, U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-2130-1; Lot #: J871033187, Exp 9/20 | 5,190 bottles | 51672-2130-8, 51672-2130-1 |
| D-0302-2020 | Children's Ibuprofen Oral Suspension USP, 100 mg per 5 mL, Berry Flavor, Dye-Free, Alcohol Free, 4 fl. oz.(120 mL), Distributed by: Winco Foods, LLC, Boise, ID 83704, NDC 67091-321-04; Lot #: A972834374, Exp 12/20 | 5,280 bottles | — |
What to do — step by step
Check Product Label
Look for the lot number and expiration date on the product label to determine if it is recalled.
Questions people ask
Is this product safe to use?
The product may contain small plastic particles that could cause choking or injury if ingested. It is not safe to use if you have the recalled lot numbers.
How do I know if my product is recalled?
Check the product label for the lot number and expiration date. The recalled products have specific lot numbers and expiration dates listed in the recall notice, such as J78402968 (exp 9/19) or A887230568 (exp 12/19).
What should I do if I have the recalled product?
The recall does not specify a remedy, so contact Taro Pharmaceuticals for guidance on next steps.
Contact Taro Pharmaceuticals
We’ve drafted a message you can send Taro Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-0299-2020 — Taro Pharmaceuticals Taro Pharmaceuticals Hello, I own a Taro Pharmaceuticals that is covered by recall D-0299-2020 from Taro Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0299-2020 (September 27, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0299-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.